Number of the records: 1  

ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells

  1. TitleASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells
    Author Némethová Veronika 1988-    ORCID
    Co-authors Babiaková Petra

    Teglasová Boglarka

    Uhelská Lucia 1981-

    Bábelová Andrea 1976 SAVBIOMED ; SAVEXONK ; SAVCEMEA - Biomedicínske centrum SAV    SCOPUS    RID    ORCID

    Šelc Michal 1988- SAVBIOMED ; SAVEXONK ; SAVCEMEA - Biomedicínske centrum SAV

    Jakič Kristína SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV

    Mitrovský Ondrej

    Myslivcová Denisa

    Zacková Markéta

    Poturnayová Alexandra 1982- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV    SCOPUS    ORCID

    Bátorová Angelika

    Drgoňa Ľuboš

    Rázga Filip 1979-    ORCID

    Source document American Journal of Physiology - Cell Physiology. Vol. 327, no. 1 (2024), pp. C184-C192
    Languageeng - English
    CountryUS - United States of America
    URLURL link
    Document kindrozpis článkov z periodík (rbx)
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2024
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1152/ajpcell.00188.2024
    article

    article

    File nameAccessSizeDownloadedTypeLicense
    asp210-a-potent-oligonucleotide-based-inhibitor-effective-against-tki-resistant-cml-cells.pdfavailable2.2 MB2Publisher's version
    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    202420235Q11.711Q1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.